Biglycan Deletion Alters Adiponectin Expression in Murine Adipose Tissue and 3T3-L1 Adipocytes

PLoS ONE

Volumn 7, Issue 11, 2012, Pages

  Ward, Meliza G ^a   Ajuwon, Kolapo M ^a  

^a PURDUE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADIPONECTIN; BIGLYCAN; INSULIN; MESSENGER RNA;

ADIPOCYTE; ADIPONECTIN BLOOD LEVEL; ADIPOSE TISSUE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; EPIDIDYMIS FAT; FEMALE; GENE EXPRESSION; INSULIN BLOOD LEVEL; LIPID DIET; LIPID STORAGE; LOW FAT DIET; MACROPHAGE; MALE; MOUSE; NONHUMAN; OBESITY; PROTEIN BLOOD LEVEL; PROTEIN DEGRADATION; PROTEIN DEPLETION; PROTEIN EXPRESSION; PROTEIN PROTEIN INTERACTION; PROTEIN SECRETION; WHITE ADIPOSE TISSUE;

3T3-L1 CELLS; ADIPOCYTES; ADIPONECTIN; ADIPOSE TISSUE; ANIMALS; BIGLYCAN; CULTURE MEDIA, CONDITIONED; FEMALE; GENE DELETION; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENE KNOCKDOWN TECHNIQUES; MACROPHAGES; MICE;

MURINAE; MUS;

EID: 84870047855     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0050554     Document Type: Article

References (45)

1. Iozzo RV, (1999) The biology of the small leucine-rich proteoglycans. J of Biol Chem 274: 18843-18846.
2. Hildebrand A, Romaris M, Rasmussen LM, Heinegard D, Twardzik DR, et al. (1994) Interaction of the small interstitial proteoglycans biglycan, decorin and fibromodulin with transforming growth factor beta. Biochemical J 302: 527-534.
3. Schönherr E, Witsch-Prehm P, Harrach B, Robenek H, Rauterberg J, et al. (1995) Interaction of Biglycan with Type I Collagen. J Biol Chem 270: 2776-2783.
4. Young MF, Bi Y, Ameye L, Chen XD, (2002) Biglycan knockout mice: New models for musculoskeletal diseases. Glycoconj J 19: 257-262.
5. Babelova A, Moreth K, Tsalastra-Greul W, Zeng-Brouwers J, Eickelberg O, et al. (2009) Biglycan, a danger signal that activates the NLRP3 inflammasome via toll-like and P2X receptors. J Biol Chem 284: 24035-24048.
6. Schaefer L, Babelova A, Kiss E, Hausser HJ, Baliova M, et al. (2005) The matrix component biglycan is proinflammatory and signals through toll-like receptors 4 and 2 in macrophages. J Clin Invest 115: 2223-2233.
7. Adapala VJ, Adedokun SA, Considine RV, Ajuwon KM, (2011) Acute inflammation plays a limited role in the regulation of adipose tissue COL1A1 protein abundance. J Nutr Biochem 23: 567-572.
8. Huber J, Loffler M, Bilban M, Reimers M, Kadl A, et al. (2006) Prevention of high-fat diet-induced adipose tissue remodeling in obese diabetic mice by n-3 polyunsaturated fatty acids. Int J Obes 31: 1004-1013.
9. Hung SC, Chang CF, Ma HL, Chen TH, Low-Tone Ho L, (2004) Gene expression profiles of early adipogenesis in human mesenchymal stem cells. Gene 340: 141-150.
10. Molina H, Yang Y, Ruch T, Kim J-W, Mortensen P, et al. (2009) Temporal profiling of the adipocyte proteome during differentiation using a 5-plex SILAC based strategy. J Proteome Res 8: 48-58.
11. Zhong J, Krawczyk SA, Chaerkady R, Huang H, Goel R, et al. (2010) Temporal Profiling of the Secretome during Adipogenesis in Humans. Proteome Res 9: 5228-5238.
12. Hausman GJ, Richardson RL, (2004) Adipose tissue angiogenesis. J Anim Sci 82: 925-934.
13. Khan T, Muise ES, Iyengar P, Wang ZV, Chandalia M, et al. (2008) Metabolic dysregulation and adipose tissue Fibrosis: role of collagen VI. Mol Cell Biol 29: 1575-1591.
14. Arita Y, Kihara S, Ouchi N, Takahashi M, Maeda K, et al. (1999) Paradoxical decrease of an adipose-specific protein, adiponectin, in obesity. Biochem Biophys Res Commun 257: 79-83.
15. Kadowaki T, (2006) Adiponectin and adiponectin receptors in insulin resistance, diabetes, and the metabolic syndrome. J Clin Invest 116: 1784-1792.
16. Yamauchi T, Kamon J, Minokoshi Y, Ito Y, Waki H, et al. (2002) Adiponectin stimulates glucose utilization and fatty-acid oxidation by activating AMP-activated protein kinase. Nat Med 8: 1288-1295.
17. Yamauchi T, Kamon J, Waki H, Terauchi Y, Kubota N, et al. (2001) The fat-derived hormone adiponectin reverses insulin resistance associated with both lipoatrophy and obesity. Nat Med 7: 941-946.
18. Xu T, Bianco P, Fisher LW, Longenecker G, Smith E, et al. (1998) Targeted disruption of the biglycan gene leads to an osteoporosis-like phenotype in mice. Nat Genet 20: 78-82.
19. Schaefer L, Babelova A, Kiss E, Hausser HJ, Baliova M, et al. (2005) The matrix component biglycan is proinflammatory and signals through toll-like receptors 4 and 2 in macrophages. J Clin Invest 115: 2223-2233.
20. Melchior-Becker A, Dai G, Ding Z, Schäfer L, Schrader J, et al. (2011) Deficiency of biglycan causes cardiac fibroblasts to differentiate into a myofibroblast phenotype. J Biol Chem 286: 17365-17375.
21. Nielsen KL, Allen MR, Bloomfied SA, Andersen TL, Chen XD, et al. (2003) Biglycan deficiency interferes with ovariectomy-induced bone loss. J Bone and Miner Res 18: 2152-2158.
22. Kumazawa M, Kobayashi M, Io F, Kawai T, Nishimura M, et al. (2007) Searching for genetic factors of fatty liver in SMXA-5 mice by quantitative trait loci analysis under a high-fat diet. J Lipid Res 48: 2039-2046.
23. Phan LK, Lin F, LeDuc CA, Chung WK, Leibel RL, (2002) The mouse mahoganoid coat color mutation disrupts a novel C3HC4 RING domain protein. Journal of Clinical Investigation 110: 1449-1459.
24. Huang J, Gabrielsen JS, Cooksey RC, Luo B, Boros LG, et al. (2007) Increased Glucose Disposal and AMP-dependent Kinase Signaling in a Mouse Model of Hemochromatosis. J Biol Chem 282: 37501-37507.
25. Herrero L, Shapiro H, Nayer A, Lee J, Shoelson SE, (2010) Inflammation and adipose tissue macrophages in lipodystrophic mice. PNAS 107: 240-245.
26. Ajuwon KM, Spurlock ME, (2005) Palmitate Activates the NF-kappaB Transcription Factor and Induces IL-6 and TNFalpha Expression in 3T3-L1 Adipocytes. The Journal of Nutrition 135: 1841-1846.
27. Barnea M, Shamay A, Stark AH, Madar Z, (2006) A high-fat diet has a tissue-specific effect on adiponectin and related enzyme expression. Obesity (Silver Spring) 14: 2145-2153.
28. Qiao L, Lee B, Kinney B, Yoo HS, Shao J, (2011) Energy intake and adiponectin gene expression. Am J Physiol Endocrinol Metab 300: E809-E816.
29. Griffin TM, Fermor B, Huebner JL, Kraus VB, Rodriguiz RM, (2010) Diet-induced obesity differentially regulates behavioral, biomechanical, and molecular risk factors for osteoarthritis in mice. Arthritis Res Ther 12: R130.
30. Weisberg SP, McCann D, Desai M, Rosenbaum M, Leibel RL, et al. (2003) Obesity is associated with macrophage accumulation in adipose tissue. J Clin Invest 112: 1796-1808.
31. Crandall DL, Hausman GJ, Kral JG, (1997) A review of the microcirculation of adipose tissue: anatomic, metabolic, and angiogenic perspectives. Microcirculation 4: 211-232.
32. Henegar C, Tordjman J, Achard V, Lacasa D, Cremer I, et al. (2008) Adipose tissue transcriptomic signature highlights the pathological relevance of extracellular matrix in human obesity. Genome Biol 9: R14.
33. Maquoi E, Munaut C, Colige A, Collen D, Lijnen HR, (2002) Modulation of adipose tissue expression of murine matrix metalloproteinases and their tissue inhibitors with obesity. Diabetes 51: 1093-1101.
34. Ward M, Ajuwon KM, (2011) Regulation of pre-adipocyte proliferation and apoptosis by the small leucine-rich proteoglycans, biglycan and decorin. Cell Proliferation 44: 343-351.
35. Bolton K, Segal D, Walder K, (2012) The small leucine-rich proteoglycan, biglycan, is highly expressed in adipose tissue of Psammomys obesus and is associated with obesity and type 2 diabetes. Biologics 6: 67-72.
36. Arita Y, Kihara S, Ouchi N, Takahashi M, Maeda K, et al. (1999) Paradoxical decrease of an adipose-specific protein, adiponectin, in obesity. Biochem Biophys Res Commun 257: 79-83.
37. Yang WS, Lee WJ, Funahashi T, Tanaka S, Matsuzawa Y, et al. (2001) Weight reduction increases plasma levels of an adipose-derived anti-inflammatory protein, adiponectin. J Clin Endocrinol Metab 86: 3815-3819.
38. Kobayashi K, Inoguchi T, Sonoda N, Sekiguchi N, Nawata H, (2005) Adiponectin inhibits the binding of low-density lipoprotein to biglycan, a vascular proteoglycan. Biochem Biophys Res Commun 335: 66-70.
39. Wiberg C, Heinegård D, Wenglén C, Timpl R, Mörgelin M, (2002) Biglycan organizes Collagen VI into hexagonal-like networks resembling tissue structures. J Biol Chem 277: 49120-49126.
40. Chen SJ, Yen CH, Huang YC, Lee BJ, Hsia S, et al. (2012) Relationships between inflammation, adiponectin, and oxidative stress in metabolic syndrome. PLoS One 7: e45693.
41. Zamboni M, Di Francesco V, Garbin U, Fratta Pasini A, Mazzali G, et al. (2007) Adiponectin gene expression and adipocyte NF-kappaB transcriptional activity in elderly overweight and obese women: inter-relationships with fat distribution, hs-CRP, leptin and insulin resistance. Int J Obes (Lond) 31: 1104-1109.
42. Bahceci M, Gokalp D, Bahceci S, Tuzcu A, Atmaca S, et al. (2007) The correlation between adiposity and adiponectin, tumor necrosis factor alpha, interleukin-6 and high sensitivity C-reactive protein levels. Is adipocyte size associated with inflammation in adults? J Endocrinol Invest 30: 210-214.
43. Combs TP, Wagner JA, Berger J, Doebber T, Wang WJ, et al. (2002) Induction of adipocyte complement-related protein of 30 kilodaltons by PPARgamma agonists: a potential mechanism of insulin sensitization. Endocrinology 143: 998-1007.
44. Ruan H, Pownall HJ, Lodish HF, (2003) Troglitazone antagonizes tumor necrosis factor-alpha-induced reprogramming of adipocyte gene expression by inhibiting the transcriptional regulatory functions of NF-kappaB. J Biol Chem 278: 28181-28192.
45. Adapala VJ, Ward M, Ajuwon K, (2012) Adipose tissue biglycan as a potential antiinflammatory target of sodium salicylate in mice fed a high fat diet. Journal of Inflammation 9: 15.